Accordingly, we showed that conjugation of cholesterol to the peptide hormone oxyntomodulin, a co-agonist of the GLP-1 and glucagon receptors with antidiabetic and anti-obesity activity, produced a substantial increase in biological potency (18, 52). Here, GCG is linked to obesity disorder.